Finerenone Shows Consistent Efficacy in Heart Failure Regardless of Atrial Fibrillation Status: Study Dr Riya Dave11 April 2025 8:15 AM ISTResearchers have discovered in a study published in JAMA Cardiology that finerenone offers stable benefits in heart failure (HF) patients with mildly...
Bayer Finerenone secures USFDA Priority Review designation for heart failure Ruchika Sharma17 March 2025 4:30 PM ISTBerlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug Administration (FDA) for finerenone...
Finerenone Benefits in HF With Mildly Reduced or Preserved Ejection Fraction Regardless of Baseline Risk: JAMA Medha Baranwal10 March 2025 9:15 AM ISTUK: A secondary analysis of the FINEARTS-HF randomized clinical trial evaluated the performance of the PREDICT-HFpEF model in estimating heart failure...
Finerenone May Help Prevent Worsening Heart Failure, suggests JAMA study Dr Riya Dave1 March 2025 9:00 AM ISTA new study published in JAMA Cardiology identified that outpatient worsening heart failure (HF) events necessitating oral diuretic escalation are...
Oral finerenone may reduce risk of new-onset diabetes in heart failure patients: Lancet Jacinthlyn Sylvia10 Feb 2025 8:15 AM ISTA recent study from the FINEARTS-HF trial revealed that finerenone, which is an oral mineralocorticoid receptor antagonist, significantly reduces the...
Bayer seeks approval of finerenone in heart failure in EU Ruchika Sharma5 Feb 2025 11:30 AM ISTBerlin: Bayer has announced the submission of a marketing authorization application to the European Medicines Agency (EMA), seeking approval in...
Bayer seeks USFDA nod for Finerenone for adult patients with heart failure Ruchika Sharma11 Jan 2025 12:37 PM ISTBerlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration (US FDA) and to the...
Finerenone Proven Effective in Reducing Heart Failure Events Across Genders in FINEARTS-HF Trial Medha Baranwal19 Dec 2024 9:00 AM ISTUK: In a secondary analysis of the FINEARTS-HF randomized clinical trial, researchers found that finerenone, a novel non-steroidal mineralocorticoid...
Which are High-impact clinical trials that may generate promising results for improving kidney health? Dr Kartikeya Kohli1 Nov 2024 8:00 PM ISTThe results of numerous high-impact phase 3 clinical trials that could affect kidney-related medical care will be presented in-person at ASN Kidney...
Finerenone improves long-term survival benefits in patients with worsening heart failure, finds study Jacinthlyn Sylvia18 Oct 2024 8:00 AM ISTA recent study published in the Journal of American Medical Association showed a projection that long-term finerenone medication can increase...
FINEARTS-HF Trial: Finerenone Offers Significant Benefits for HF Patients Following Recent Worsening Events Dr. Prem Aggarwal1 Oct 2024 6:00 AM ISTUSA: The FINEARTS-HF trial revealed that the benefit-risk profile of finerenone (Kerendia) for heart failure with mildly reduced or preserved ejection...
Finerenone may reduce worsening heart failure and cardiovascular death, finds study, ESC 2024 Dr. Kamal Kant Kohli4 Sept 2024 6:00 AM ISTFinerenone reduced the composite of total first and recurrent heart failure (HF) events (hospitalizations for HF or urgent HF visits) and...
